US judge rules against GSK in trade secrets dispute
By 
Rebecca Trager2021-06-25T09:48:00
Firm will not receive compensation for claimed loses of over $1bn from theft of confidential information by two former scientists
A US district court judge has ruled that GlaxoSmithKline (GSK) was not financially harmed by the theft of trade secrets by of two of its former scientists. The company will therefore receive no compensation and will have to cover its own legal expenses, estimated at nearly $400,000 (£288,000).